Bristol Myers Squibb's Yervoy contract with Belfast Trust ends early
- Belfast Health and Social Care Trust
- Northern Ireland
- Direct award
- 7 July 2026 to 30 June 2028
Belfast Health and Social Care Trust bought the oncology medicine Yervoy (ipilimumab) from Bristol Myers Squibb. The medicine came as a concentrate for infusion, in packs of one vial.
The trust awarded the £2m contract directly in June 2026, to run for two years. The trust ended the contract in October 2026, and no reason was given.
Contract ends June 2028
- What
- Medicines supply
- Supplier
- Bristol Myers Squibb
- Value
- £2m
- How it was bought
- Direct award
- Dates and next
- Jul 2026 to Jun 2028